Literature DB >> 8704522

St John's wort as an antidepressant.

P A De Smet, W A Nolen.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8704522      PMCID: PMC2351659          DOI: 10.1136/bmj.313.7052.241

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

2.  Should herbal medicine-like products be licensed as medicines.

Authors:  P A De Smet
Journal:  BMJ       Date:  1995-04-22

3.  Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160.

Authors:  K D Hänsgen; J Vesper; M Ploch
Journal:  J Geriatr Psychiatry Neurol       Date:  1994-10       Impact factor: 2.680

4.  Inhibition of MAO by fractions and constituents of hypericum extract.

Authors:  S Bladt; H Wagner
Journal:  J Geriatr Psychiatry Neurol       Date:  1994-10       Impact factor: 2.680

5.  Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.

Authors:  H Woelk; G Burkard; J Grünwald
Journal:  J Geriatr Psychiatry Neurol       Date:  1994-10       Impact factor: 2.680

  5 in total
  7 in total

1.  Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.

Authors:  M Philipp; R Kohnen; K O Hiller
Journal:  BMJ       Date:  1999-12-11

Review 2.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

3.  St John's wort for depression.

Authors:  P J Houghton
Journal:  BMJ       Date:  1996-11-09

4.  Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.

Authors:  H Woelk
Journal:  BMJ       Date:  2000-09-02

5.  Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design.

Authors:  S Kasper; A Dienel; M Kieser
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

6.  St John's wort or sertraline? Randomized controlled trial in primary care.

Authors:  Gerald van Gurp; Greg B Meterissian; Laura N Haiek; Jane McCusker; François Bellavance
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

7.  Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].

Authors:  Shahin Akhondzadeh; Hasan Fallah-Pour; Khosro Afkham; Amir-Hossein Jamshidi; Farahnaz Khalighi-Cigaroudi
Journal:  BMC Complement Altern Med       Date:  2004-09-02       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.